Patients who received the Tecnis PureSee extended depth of focus IOL had a high tolerance to residual refractive error, ...
Patients with bilateral limbal cell deficiency or previous failed keratoplasty may be candidates for KPro, according to a ...
Semaglutide use was not tied to a higher risk for non-arteritic anterior ischemic optic neuropathy, or NAION, in patients ...
Non-FDA-approved GLP-1 receptor agonists remain largely available despite recent resolutions to drug shortages, data at the ...
Alcon launched its Clareon TruPlus enhanced monofocal and toric IOLs in the U.S., according to a press release.The lens ...
Structured de-escalation of GLP-1 receptor agonists may lead to sustained health benefits while reducing treatment burden, ...
When preparing for cataract surgery in patients with retinal pathologies, ophthalmologists must be sure to set reasonable ...
The best candidates for corneal tissue addition keratoplasty fit certain topographical and visual criteria, according to a ...
The direction of the risk for Alzheimer’s disease and related dementias differed based on the quality of a plant-based diet, ...
Adults with type 2 diabetes and overweight or obesity who use a GLP-1 receptor agonist have similar risk for kidney cancer as ...
Women who have two or more cardiometabolic risk factors were linked to a higher likelihood of significant liver fibrosis compared to men with the same risk factors, according to cross-sectional study ...
The FDA has released a statement saying it will “carefully shepherd” studies to advance the development of chimeric antigen receptor T-cell therapies in autoimmune and rheumatic diseases.“It is quite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results